Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Impaired monocyte-derived dendritic cell phenotype in prostate cancer patients: A phenotypic comparison with healthy donors.

Cancer reports (Hoboken, N.J.) - 1 Feb 2024

Bakhshi Parisa, Nourizadeh Maryam, Sharifi Laleh, Nowroozi Mohammad R, Mohsenzadegan Monireh, Farajollahi Mohammad M

Abstract excerpt

BACKGROUND: Dendritic cells (DCs) play a crucial role in immunity. Research on monocyte-derived DCs (Mo-DCs) cancer vaccines is in progress despite limited success in clinical trials. This study focuses on Mo-DCs generated from prostate cancer (PCA) patients, comparing them with DCs from healthy donors (HD-DCs). METHODS: Mo-DCs were isolated from PCA patient samples, and their phenotype was compared to HD-DCs....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to B7-1 Antigen
Share to Cell Differentiation

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Dendritic Cells

Share to HLA-DR Antigens

Share to Monocytes

Share to Phenotype

Share to Prostatic Neoplasms

Share to Vaccines

Source

Open in PubMed Open full text

Identifiers

PMID: 38351552
DOI: 10.1002/cnr2.1996
PMCID: PMC10864738

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Impaired monocyte-derived dendritic cell phenotype in prostate cancer patients: A phenotypic comparison with healthy donors.PMID 38351552Read ↗

Compromised functionality of monocyte-derived dendritic cells in multiple myeloma patients may limit their use in cancer immunotherapy.Semantic proximity Read ↗

Quantitative and qualitative impairments in dendritic cell subsets of patients with ovarian or prostate cancer.Semantic proximity Read ↗

Monocyte-derived dendritic cells: targets as potent antigen-presenting cells for the design of vaccines against infectious diseases.Semantic proximity Read ↗

Binding of prostate-specific membrane antigen to dendritic cells: a critical step in vaccine preparation.Semantic proximity Read ↗

Generation of dendritic cells from human bone marrow mononuclear cells: advantages for clinical application in comparison to peripheral blood monocyte derived cells.Semantic proximity Read ↗

Impaired functionality and phenotypic profile of dendritic cells from patients with multiple myeloma.Semantic proximity Read ↗

Comparison of CD34 and monocyte-derived dendritic cells from mobilized peripheral blood from cancer patients.Semantic proximity Read ↗

Clinical-scale generation of dendritic cells in a closed system.Semantic proximity Read ↗

Dendritic Cells Differentiated from Human Umbilical Cord Blood-Derived Monocytes Exhibit Tolerogenic Characteristics.Semantic proximity Read ↗

Impact of interleukin-10 on phenotype and gene expression during early monocyte differentiation into dendritic cells.Semantic proximity Read ↗

Comprehensive Phenotyping of Human Dendritic Cells and Monocytes.Semantic proximity Read ↗

Phenotypic and functional characteristics of dendritic cells derived from human peripheral blood monocytes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.